| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |